Compare BNTC & RMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BNTC | RMR |
|---|---|---|
| Founded | 1995 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 396.3M | 350.2M |
| IPO Year | 2020 | 2015 |
| Metric | BNTC | RMR |
|---|---|---|
| Price | $9.54 | $18.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $27.67 | $19.00 |
| AVG Volume (30 Days) | ★ 124.1K | 71.9K |
| Earning Date | 05-14-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 10.37% |
| EPS Growth | ★ 6.67 | N/A |
| EPS | N/A | ★ 0.95 |
| Revenue | N/A | ★ $700,284,000.00 |
| Revenue This Year | N/A | $259.61 |
| Revenue Next Year | N/A | $2.45 |
| P/E Ratio | ★ N/A | $19.77 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.26 | $14.27 |
| 52 Week High | $16.76 | $21.45 |
| Indicator | BNTC | RMR |
|---|---|---|
| Relative Strength Index (RSI) | 25.23 | 36.96 |
| Support Level | N/A | $17.88 |
| Resistance Level | $13.49 | $20.52 |
| Average True Range (ATR) | 0.74 | 0.37 |
| MACD | -0.26 | -0.03 |
| Stochastic Oscillator | 6.18 | 6.37 |
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on advancing novel genetic medicines. Its technology could provide a one-shot cure for a wide range of diseases that require strict, ongoing treatment regimens or have no effective treatment or only palliative care options. The Company is developing a silence-and-replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The company has a single operating segment, which is the business of discovery and development of therapeutic agents for the treatment of genetic disorders.
The RMR Group Inc is a U.S. based real estate investment manager engaged in commercial real estate, private capital, and credit strategies. Its portfolio covers various commercial real estate asset classes, and it manages investments across various industries, geographies and asset classes.